Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
about
Lipid-lowering efficacy of atorvastatinStatins for the primary prevention of cardiovascular diseaseLipid lowering efficacy of atorvastatinStatins for the primary prevention of cardiovascular diseaseStatins and fibrates for preventing melanomaQuantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisNational trends in statin use by coronary heart disease risk categoryManagement of intracerebral hemorrhage--use of statinsThyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?A novel therapeutic effect of statins on nephrogenic diabetes insipidusOptimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care settingThe use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary interventionHibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studiesDid the major clinical trials of statins affect prescribing behaviour?Factors Associated with Lipid Goal Attainment among Patients with Deployed Drug Eluting StentClinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes RegisterDifferential mitochondrial toxicity screening and multi-parametric data analysisHigh Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD CohortCarriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean malesDose-dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with HyperlipidemiaPossible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsPreferred drug lists: potential impact on healthcare economics.Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study.Effects of fluvastatin on plasma levels of low-density lipoprotein subfractions, oxidized low-density lipoprotein, and soluble adhesion molecules: a twenty-four-week, open-label, dose-increasing studyA six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap studyA cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study.Comparison of effects of different statins on growth and steroidogenesis of rat ovarian theca-interstitial cells.Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetesUnintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseMeta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia.Fundamental cause theory, technological innovation, and health disparities: the case of cholesterol in the era of statins.Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study.Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatinPhysiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?Role of statin in atrial fibrillation-related stroke: an angiographic study for collateral flow.Dyslipidaemia and cardiovascular risk in diabetes.Pharmacotherapy of hypercholesterolaemia: statins in clinical practice.Twenty questions on atherosclerosis.
P2860
Q24187301-7A78CC22-5E10-4BB9-80AD-7A2431260817Q24201513-3C9ED609-1B35-476A-902E-53E369936D44Q24202363-D4439FF9-23FD-4E9A-AD2A-7A399F3B6FA5Q24234813-00C04394-5F31-481F-8080-8A1441169A2AQ24245521-FE6265AE-E399-4A35-B910-1F8399D6CFD7Q24679573-C8109898-6124-499C-AE27-B8D1BF6939A9Q24810059-5412C856-5E0D-42AA-803D-20AFAE26C099Q26752952-6B17BEE3-6C6E-4896-AABD-E8AE008310D4Q26995671-E60F09CB-40E0-4DC5-B5CD-10D90DCA9459Q27005638-107E5460-9969-4AAB-9717-81A29B5C1F67Q28193213-F1080F7E-0C53-478C-AF70-F99E976E6756Q28196775-7CF73211-4C73-41F4-8D4A-6E52EA18CA68Q28283749-86027666-7109-492A-9B01-75FF17AD2246Q28343786-BEA57D04-4078-42B3-9869-0A8DC3599419Q28468714-9CA8799E-D460-4AFC-906D-8A4649F3AE96Q28477948-4115CBB9-B97D-49D0-B679-4FE714238053Q28484406-2D7C494A-DFD4-49E5-81D0-6C87E24E103AQ28550768-86286289-9F89-483F-8D63-9842825F77CEQ28741376-140ECCA1-3426-4ECD-8085-8839649636AEQ30422488-8B45A17E-A7D4-43CA-A807-A8221D1F8B0BQ30814231-1B8231DE-3C31-4812-8DC4-334BDE32B370Q33344612-EF9283FC-2FE0-4683-A955-9BE03CCA436AQ33691624-BE8885F0-C950-4CD8-8D83-66E9D83403F7Q33738872-6D23D96A-576D-41D4-A14A-484A9EFB7826Q33738930-DAC8CD14-7335-472F-85DB-D7F9A6087ABEQ33743492-1A6DC9FB-FC82-4822-B682-372837725CA2Q33826357-33FA032F-0709-4CF2-9133-C77982A41FC8Q33827363-3C0C87D2-3A1A-4FCF-848D-0F14DC8DF5B5Q33867311-6F205A83-40CD-4770-8F27-08278B665568Q33902665-472DDE79-F477-4A36-8D35-CF4CE1839EB6Q33911017-31AE9005-57B9-469D-AB96-8800657631C4Q33911031-C4EC8B81-A21F-49ED-899F-CCEBD46E02B3Q33935872-A2372A8C-D75A-4C98-9880-D2220621BFD3Q33938868-56563D64-A040-418D-A429-0655A1698B7CQ34016327-070585BB-3F8F-4819-9CEB-F173AF521CA5Q34066977-821E8E9A-1889-4199-832F-DAB48EA278F6Q34150277-78A50288-60BF-4B32-B1C7-C7AF14545B22Q34168379-433D93AB-C105-4641-9469-D8180BA09E54Q34182077-CFB23315-D237-4E4F-997D-8D1CD5A9C70EQ34212434-07B3C7B0-BCDF-488B-8EAD-1BEE6ABD20E6
P2860
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@ast
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@en
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@nl
type
label
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@ast
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@en
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@nl
prefLabel
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@ast
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@en
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@nl
P2093
P1476
Comparative dose efficacy stud ...... esterolemia (the CURVES study)
@en
P2093
P304
P356
10.1016/S0002-9149(97)00965-X
P407
P577
1998-03-01T00:00:00Z